Sampre Nutritions (BOM:530617) Other Financing: ₹0.0 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:530617 Sampre Nutritions Ltd BOM:530617
58 GF Score
Price ₹5.98
GF Value ₹8.93
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is Sampre Nutritions Other Financing?

Sampre Nutritions BOM:530617 -4.93% 58 Other Financing is ₹0.0 Mil as of Jun. 2026. GuruFocus rates BOM:530617 with a GF Score™ of 58/100 and a GF Value™ of ₹8.93 (Significantly Undervalued). The stock has 5 warning signs investors should review.

Sampre Nutritions's Other Financing for the three months ended in Jun. 2026 was ₹0.0 Mil.

Sampre Nutritions's Other Financing for the trailing twelve months (TTM) ended in Jun. 2026 was ₹0.0 Mil.

Sampre Nutritions Other Financing Historical Data

* Premium members only.

The historical data trend for Sampre Nutritions's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sampre Nutritions Other Financing Chart

Sampre Nutritions Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Other Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only -16.72 -17.77 -19.04 -16.98 -11.16

Sampre Nutritions Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
BOM:530617
58GF Score
Sampre Nutritions Ltd BOM:530617
Other Financing is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sampre Nutritions Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Financing →
What does a Other Financing of ₹0.0 Mil mean?
Sampre Nutritions (BOM:530617) has a Other Financing of ₹0.0 Mil as of Jun. 2026. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Sampre Nutritions and its competitors.
Is Sampre Nutritions' Other Financing too high?
Sampre Nutritions' current Other Financing is ₹0.0 Mil. Overall, Sampre Nutritions has a GF Score™ of 58/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sampre Nutritions' Other Financing compare to MDLZ and HSY?
Sampre Nutritions' Other Financing of ₹0.0 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Financing for a Consumer Packaged Goods company?
A good Other Financing depends on the Consumer Packaged Goods industry context. However, Other Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Financing mean?
A high Other Financing can signal that a stock is expensive relative to its fundamentals. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Sampre Nutritions and its competitors. Sampre Nutritions's current Other Financing is ₹0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sampre Nutritions stock overvalued right now?
Based on GuruFocus' analysis, Sampre Nutritions (BOM:530617) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹8.93, compared to a current price of ₹5.98 — trading 33% below its estimated fair value. The current Other Financing is ₹0.0 Mil. Sampre Nutritions' overall GF Score™ is 58/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Financing calculated?
Other Financing is calculated from a company's financial statements. For Sampre Nutritions (BOM:530617), the current Other Financing is ₹0.0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sampre Nutritions (BOM:530617) Overvalued in 2026?

Based on GuruFocus' analysis, Sampre Nutritions stock appears to be undervalued. The current stock price of ₹5.98 is trading 33% below its estimated GF Value™ of ₹8.93. GuruFocus considers Sampre Nutritions to be Significantly Undervalued.

Key valuation signals for BOM:530617:

  • Other Financing: ₹0.0 Mil
  • GF Value™: ₹8.93 vs. price of ₹5.98 (33% below fair value)
  • GF Score™: 58/100 with 5 warning signs

No single metric tells the full story. See the BOM:530617 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sampre Nutritions Business Description

Address Plot No. 133, Industrial Estate, Medchal, Hyderabad, TG, IND, 501 401
Sampre Nutritions Ltd is engaged in manufacturing of confectionaries. The company is engaged in manufacturing complete range of confectionery, eclairs, candies, toffees, powder and centre filled products. The company caters to the demands of majority of the MNC's besides having their own brand of products. Sampre Nutrition is an ISO certified company in Southeast Asia in this category and is also HACCP Certified Company by BVQI and FSSA certified company. Maximum of company's revenue is from India.
58GF Score

Get the complete analysis for BOM:530617

Other Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹5.98
Price
₹8.93
GF Value